Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector.
The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.
With its comprehensive database tracking over 2,500 capital raises and 1,000 M&A transactions totaling more than $65 billion since 2015, it offers vital market intelligence for strategic decision-making.
39% Market Value Rise
Over the past year, the majority of the 14 major cannabis companies have seen their market value increase compared to their expected earnings.
A year-on-year comparison from April 14, 2023, to April 12, 2024, reveals an overall increase in Enterprise Value to Consensus Next Twelve-Month (NTM) EBITDA multiples for the majority of the 14 major MSOs analyzed.
Eleven out of these fourteen companies have seen their valuation multiples rise, with increases ranging from 3% to a remarkable 70%.
As a group, these cannabis companies have seen their overall market value rise by 39%, indicating they’re now valued higher compared to their future profits.
This growth has resulted in the group’s aggregate EV/NTM EBITDA multiple expanding from 6.13x to 8.53x.